-
pso.ahrq.gov/pso/listed/geographic/printable-list
Phone Number: (205) 968-7057 Point of Contact Phone: (205) 968-4448 Disclosures & Findings: None Subject … 501) 537-7942 Point of Contact Email: siorio@americandatanetwork.com Disclosures & Findings: None Subject … Phone Number: (479) 360-4289 Point of Contact Phone: (479) 360-4289 Disclosures & Findings: None Subject … (480) 794-0483 Point of Contact Email: lmead@strategicradiology.org Disclosures & Findings: None Subject … Site: http://www.chpso.org Point of Contact Phone: (916) 552-2611 Disclosures & Findings: None Subject
-
pso.ahrq.gov/pso/listed/printable-list
December 22, 2010 - Contact: Jennifer Clair MacCready Point of Contact Phone: (617) 450-5565 Disclosures & Findings: None Subject … of Contact: Kristen DeDent Point of Contact Phone: (469) 868-2043 Disclosures & Findings: None Subject … Contact: Stephanie Hogberg Point of Contact Phone: (615) 296-3457 Disclosures & Findings: None Subject … Tarafa Point of Contact Phone: (847) 268-9159 Disclosures & Findings: None Subject to FDA-Regulated … Kopec Point of Contact Phone: (731) 968-3646 Disclosures & Findings: None Subject to FDA-Regulated
-
pso.ahrq.gov/sites/default/files/Patient%20Safety%20Act%20PDF.pdf
January 01, 2025 - of the
work product, or any providers that participate in activities
that are a subject of the work … —Notwithstanding any other provision of Fed-
eral, State, or local law, and subject to subsection (c) … , patient
safety work product shall be privileged and shall not be—
‘‘(1) subject to a Federal, State … —Subject to paragraphs (2)
and (3), a person who discloses identifiable patient safety work
product … in knowing or reckless violation of subsection (b) shall
be subject to a civil monetary penalty of not
-
pso.ahrq.gov/resources/guides
August 01, 2023 - Terms of Use Disclaimer
This video currently titled "Working with a PSO: One Approach," is subject … information presented is not legal advice, is not to be acted on as such, may not be current, and is subject
-
pso.ahrq.gov/sites/default/files/wysiwyg/Patient-Safety-Act-2005.pdf
January 01, 2005 - of the
work product, or any providers that participate in activities
that are a subject of the work … —Notwithstanding any other provision of Fed-
eral, State, or local law, and subject to subsection (c) … , patient
safety work product shall be privileged and shall not be—
‘‘(1) subject to a Federal, State … —Subject to paragraphs (2)
and (3), a person who discloses identifiable patient safety work
product … in knowing or reckless violation of subsection (b) shall
be subject to a civil monetary penalty of not
-
pso.ahrq.gov/pso/caring-communities-patient-safety-organization-llc
August 07, 2024 - Requirement: Next attestation period is 08/07/2024
through 08/06/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/advancing-healthcare-debriefing-quality-patient-safety-organization
April 03, 2025 - Requirement: Next attestation period is 04/03/2025
through 04/02/2027
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/bradenhealth-patient-safety-organization
April 28, 2020 - Requirement: Next attestation period is 04/28/2024
through 04/27/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/care-standards-organization-llc
September 12, 2019 - Requirement: Next attestation period is 09/12/2025
through 09/11/2027
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/caresyntax-patient-safety-organization
September 04, 2019 - Requirement: Next attestation period is 09/04/2025
through 09/03/2027
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/access-telecare-patient-safety-institute-llc
November 02, 2021 - Requirement: Next attestation period is 11/02/2023
through 11/01/2025
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/american-osteopathic-association-pso
March 16, 2022 - Requirement: Next attestation period is 03/16/2024
through 03/15/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/apmd-quality-and-patient-safety-organization-llc
May 07, 2020 - Requirement: Next attestation period is 05/07/2024
through 05/06/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/billings-clinic-quality-connect
April 08, 2020 - Requirement: Next attestation period is 04/08/2024
through 04/07/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/capsule-pharmacy-pso
January 19, 2023 - Requirement: Next attestation period is 01/19/2025
through 01/18/2027
Disclosures and Findings: None Subject
-
pso.ahrq.gov/sites/default/files/wysiwyg/guidance-pswp-provider-obligations.pdf
May 24, 2016 - ”
• “At the same time, providers are subject to legitimate external
obligations regarding certain … of the Previous
Slide:
►Paragraph (1) includes, but is not limited to, original records
that are subject … ►Paragraph (2) applies to information that is subject to a record
maintenance requirement when the … • If the provider has reported the information to a PSO or the information
is otherwise not subject … 42 CFR
3.206(b)(3)
► Is the information subject to the FDA disclosure
permission?
-
pso.ahrq.gov/pso/anesthesia-patient-safety-organization-anpso
June 24, 2021 - Requirement: Next attestation period is 06/24/2025
through 06/23/2027
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/alliance-dedicated-cancer-centers-patient-safety-organization
June 14, 2022 - Allied Diseases Memorial Sloan Kettering Cancer Center Sloan Kettering Institute for Cancer Research Subject
-
pso.ahrq.gov/pso/ahs-pso-llc
November 30, 2016 - Requirement: Next attestation period is 11/30/2024
through 11/29/2026
Disclosures and Findings: None Subject
-
pso.ahrq.gov/pso/alliance-patient-medication-safety
December 10, 2008 - Requirement: Next attestation period is 12/10/2026
through 12/09/2028
Disclosures and Findings: None Subject